Palvella Therapeutics Inc... (PVLA)
Palvella Therapeutics Statistics
Share Statistics
Palvella Therapeutics has 11.02M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 11.02M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 526 |
| FTD / Avg. Volume | 0.65% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -1.53 and the forward PE ratio is null. Palvella Therapeutics's PEG ratio is 0.
| PE Ratio | -1.53 |
| Forward PE | n/a |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 0.43 |
| P/FCF Ratio | -2.46 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Palvella Therapeutics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.33, with a Debt / Equity ratio of 0.
| Current Ratio | 7.33 |
| Quick Ratio | 7.33 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.26 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-1,245,285.71 |
| Employee Count | 14 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is -23.17, so Palvella Therapeutics's price volatility has been lower than the market average.
| Beta | -23.17 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 24.28 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 48.88 |
| Average Volume (20 Days) | 81,155 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -14.1M |
| Net Income | -17.43M |
| EBITDA | -13.12M |
| EBIT | -13.12M |
| Earnings Per Share (EPS) | -7.83 |
Balance Sheet
The company has 83.6M in cash and 0 in debt, giving a net cash position of 83.6M.
| Cash & Cash Equivalents | 83.6M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -93.73M |
| Total Assets | n/a |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was -10.84M and capital expenditures 0, giving a free cash flow of -10.84M.
| Operating Cash Flow | -10.84M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.84M |
| FCF Per Share | -4.87 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PVLA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for PVLA is $45, which is 87.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $45 |
| Price Target Difference | 87.3% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
Stock Splits
The last stock split was on Apr 23, 2024. It was a backward split with a ratio of 1:80.
| Last Split Date | Apr 23, 2024 |
| Split Type | backward |
| Split Ratio | 1:80 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |